Effect of LY2189265, a long-acting glucagon-like peptide 1 analog, on metabolic outcomes and GI events in obese patients with uncontrolled type 2 diabetes mellitus (T2DM): The EGo study.

✍ Scribed by Umpierrez, G.; Blevins, T.; Rosenstock, J.; Cheng, C.; Bastyr, E.; Anderson, J.

• Book ID: 121963510
• Publisher: Canadian Diabetes Association
• Year: 2009
• Tongue: English
• Weight: 445 KB
• Volume: 33
• Category: Article
• ISSN: 1499-2671
• DOI: 10.1016/S1499-2671(09)33073-7